Summary
Human recombinant gamma interferon (INF-γ) activated human peripheral blood monocytes to a cytotoxic state capable of lysing adherent tumorigenic cells without harming normal cells. The efficiency of INF-γ activation of monocytes is enhanced by encapsulating INF-γ within liposomes: The minimum effective dose (MED) of free INF-γ for monocyte activation was found to be 1–10 U/ml, per 105 monocytes, whereas the minimum dose for INF-γ encapsulated in liposomes was less than 0.0025 U. Monocytes treated with liposome-encapsulated INF-γ retained their cytotoxic phenotype for much longer than do monocytes treated with free INF-γ. Since liposomes can be passively targeted to cells of the reticuloendothelial system following IV administration, these findings suggest that liposome-encapsulated INF-γ may have therapeutic potential that should be evaluated in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alving CR (1982) Therapeutic potential of liposomes as drug carriers in leishmaniasis, malaria, and vaccines. In: Gregoridis G, Senior J, Trovet A (eds), Targeting of drugs. Plenum, New York, pp 373–353
Anderson P, Yip VK, Vilcek J (1983) Human interferon-γ is internalized and degraded by cultured fibroblasts. J Biol Chem 258:6579
Bourgeade MF, Chany C, Merigan TC (1980) Type I and type II interferons: differential actions in transformed cells. J Gen Virol, 46:449
Branca AA, Baglioni C (1981) Evidence that types I and II interferons have different receptors. Nature 294:768
Cameron DJ, Churchill WH (1979) Cytotoxicity of human macrophage for tumor cells: Enhancement by human lymphocyte mediators. J Clin Invest 63:977
Catalona WJ, Ratliff TL, McCool RE (1981) Gamma interferon induced by S aureus protein augments natural killing and ADCC. Nature 291:77
Churchill WH Jr, Piessens WF, Sulis CA, David JR (1975) Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol 115:781
Dean RT, Virelizier JL (1983) Interferon as a macrophage activating factor. I. Enchancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals. Clin Exp Immunol 51:501
Dianzani F, Zucca M, Scupham A, Georgiades JA (1980) Immune and virus-induced interferons may activate cells by different derepressional mechanisms. Nature 283:400
Fidler IJ (1975) Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants. J Natl Cancer Inst 55:1159
Fidler IJ (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208:1469
Fidler IJ, Raz A (1981) The induction of tumoricidal capacities in mouse and rat macrophages by lymphokines. In: Pick E (ed) Lymphokines, vol. 3. Academic, New York, pp 345–363
Fidler IJ, Raz A, Fogler WE, Hoyer LC, Poste G (1981) The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes. Cancer Res 41:495
Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G (1982) Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res 42:496
Fogler WE, Raz A, Fidler IJ (1980) In situ activation of murine macrophages by liposomes containing lymphokines. Cell Immunol 53:214
Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen CC, Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson AD, Goeddel DV (1982) Expression of human immune interferon C DNA in E. coli and monkey cells. Nature 295:503
Graybill JR, Cravin PC, Taylor RL, Williams DM, Magge WE (1982) Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis 145:748
Gregoriadis G, Allison AC (1980) Liposomes in biological systems. Wiley Interscience, New York
Izadkhah Z, Mandel AD, Sonnenfeld G (1980) Effect of treatment of mice with sera containing gamma interferon on the course of infections with Salmonella typhimurium strain LT-2. J Interferon Res 1:137
Kende M, Schroit AJ, Rill W, Canonico P (1983) Treatment of Rift Valley fever virus-infected Swiss mice with liposome encapsulated muramyl dipeptide. (Abstract) ICAAC, Las Vegas, pp 108
Kleinerman ES, Schroit AJ, Fogler WE, Fidler IJ (1983) Tumoricidal activity of human monocytes activated in vitro by free and liposome encapsulated human lymphokines. J Clin Invest 72:304
Kleinerman ES, Zickt R, Wiltrout RH, Fidler IJ (1984) A human macrophage activating factor distinct from γ-interferon. Proc Am Assoc Cancer Res 25:261
Koff, WC, Showalter SD, Seniff DA, Hampar B (1983) Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma. Infect Immun 42:1067
Koff WC, Fidler IJ, Showalter SD, Chakrabarty MK, Hampar B, Ceccorulli LM, Kleinerman ES (1984) Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells. Science 224:1007
Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J (1983) Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol, 131:2821
Mantovani A, Dean JH, Jerrells TR, Herberman RB (1980) Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines. Int J Cancer 25:691
Nathan CF, Murray HW, Wiebe ME, Rubin BY (1983) Identification of interferon — γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670
Pfefferkorn ER, Guyre PM (1983) Recombinant human gamma interferon blocks the growth of Toxoplasma gondii in cultured human fibroblasts. (Abstract) Fed Proc 42:964
Poste G, Kirsch R, Fogler W, Fidler IJ (1979) Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res 39:881
Poste G, Bucana C, Raz A, Bugelski P, Kirsh R, Fidler IJ (1982) Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42:1412
Rubin BY, Gupta SL (1980) Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci USA 77:5928
Rucco LP, Meltzer MS (1977) Macrophage activation for tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guerin-immune spleen cells cultures. J Immunol 119:889
Schroit AJ, Hart IR, Madsen J, Fidler IJ (1983a) Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states. J Biol Resp Modif 2:97
Schroit AJ, Galligioni E, Fidler IJ (1983b) Factors influencing the in situ activation of macrophages by liposomes containing muramyl dipeptide. Biol Cell 47:87
Shirahata T, Shimizu K (1980) Production and properties of immune interferon from spleen cell cultures of toxoplasma-infected mice. Microbiol Immunol 24:1109
Stewart WE, III (ed) (1981) The interferon system, 2nd edn. Springer, New York
Taramelli D, Holden HT, Varesio L (1980) Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay. J Immunol Methods 37:225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koff, W.C., Fogler, W.E., Gutterman, J. et al. Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon. Cancer Immunol Immunother 19, 85–89 (1985). https://doi.org/10.1007/BF00199714
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199714